Shearman & Sterling represented WebMD Health Corp. in connection with its Rule 144A offering of $400 million aggregate principal amount of its 2.50% Convertible Notes due 2018 (including $50 million aggregate principal amount of notes pursuant to the exercise in full of the initial purchaser’s over-allotment option). WebMD (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms and health-focused publications. In connection with the offering, WebMD repurchased 1,920,490 shares of its common stock at a price of $52.07 per share and intends to use the remainder of the net proceeds for general corporate purposes.

The Shearman & Sterling team included partners Robert Roberts III (New York-Capital Markets) and Don J. Lonczak (Washington, DC-Tax); counsel Ferdinand Erker (New York-Capital Markets) and Jung-Kyu McCann (Menlo Park-Capital Markets); and associates Matthew Harvey (San Francisco-Capital Markets), Phillip Monk (Menlo Park-Capital Markets), Gabriela Laufer (New York-Capital Markets), Daniel Stellenberg (Menlo Park-Executive Compensation & Employee Benefits), Nathan Tasso (Washington, DC-Tax) and Steven Homan (New York-Investment Funds).